Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: Clin Cancer Res. 2010 Dec 15;16(24):6100–6110. doi: 10.1158/1078-0432.CCR-10-1533

Table 2.

Hazard Ratios for Breast Cancer Specific Mortality, Stratified by Race and Menopausal Status and Adjusted for Age at Diagnosis and Date of Diagnosis

White
African American
Premenopausal (n=323) Postmenopausal (n=308) Premenopausal (n=238) Postmenopausal (n=280)


Subtype
 Luminal A 1.00 1.00 1.00 1.00
 Luminal B 1.2 (0.6, 2.5) 2.9 (1.0, 8.4) 1.2 (0.5, 2.9) 1.3 (0.5, 3.6)
 Basal-like 1.8 (1.0, 3.4) 3.9 (1.5, 10.0) 1.3 (0.8, 2.3) 1.9 (0.9, 3.8)
 HER2+/ER− 2.1 (0.9, 5.0) 4.3 (1.4, 13.6) 1.9 (0.9, 4.2) 3.1 (1.3, 7.2)
 Unclassified 1.4 (0.7, 3.0) 2.1 (0.6, 7.4) 1.0 (0.5, 2.0) 1.9 (0.8, 4.3)
Subtype combined
 Luminal A or B 1.00 1.00 1.00 1.00
 Basal-like 1.8 (1.0, 3.2) 3.0 (1.2, 7.4) 1.3 (0.8, 2.2) 1.8 (0.9, 3.6)
 HER2+/ER− 2.0 (0.9, 4.8) 3.4 (1.1, 10.3) 1.9 (0.9, 4.0) 3.0 (1.3, 6.9)
ER status
 ER+ 1.00 1.00 1.00 1.00
 ER− 1.4 (0.9, 2.2) 2.1 (1.0, 4.2) 1.3 (0.8, 2.2) 2.3 (1.3, 3.9)
PR status
 PR+ 1.00 1.00 1.00 1.00
 PR− 1.9 (1.2, 3.0) 2.1 (1.0, 4.2) 1.4 (0.9, 2.3) 1.9 (1.1, 3.4)
HER2 status
 HER2− 1.00 1.00 1.00 1.00
 HER2+ 1.2 (0.7, 2.1) 2.3 (1.1, 5.1) 1.4 (0.8, 2.5) 1.5 (0.8, 2.9)